ClinicalTrials.Veeva

Menu

Effect of Electroacupuncture on Sepsis-induced Intestinal Dysfunction

J

Jianbo Yu

Status

Unknown

Conditions

Intestinal Dysfunction
Sepsis

Treatments

Device: electroacupuncture treatment
Device: sham electroacupuncture treatment

Study type

Interventional

Funder types

Other

Identifiers

NCT04646629
NKYY_YXKT_IRB_2020_071_01

Details and patient eligibility

About

  1. Title: Effect of electroacupuncture on sepsis-induced intestinal dysfunction

  2. Research center: single center

  3. The Design of the study: Randomized, double-blind, controlled study

  4. The population of the study: The patients over 18 years that met the criteria of sepsis3.0 and with AGI grade II or above are enrolled in the study

  5. Sample size: Enroll 60 patients (30patients in each group)

  6. Interventions: Participants in the treatment group underwent 60 minutes acupuncture (0.30mm×70mm) at ST36 (Zusanli) and ST37 (Shangjuxu) twice a day for seven days. After"Deqi",electroacupuncture stimulation apparatus (HANS G6805-2, Huayi Co, Shanghai, China) is connected and maintained the end of treatment.

    Participants in the control group received shallow needling (0.30mm×25mm) at ST36 and ST37(nonacupoints located 1 inch beside acupoints, about 20mm). Specifically, the depth of needle insertion into nonacupoints is 3-5mm and avoided manual stimulation and no "Deqi" without actual current output.

  7. The aim of the research: To investigate the effect of electroacupuncture on sepsis-induced intestinal dysfunction.

  8. Outcome# 1) Primary outcome: The intestinal function indicators including: 1) Clinical symptoms: bowel sounds, intra-abdominal pressure, time to first exhaust/defecation, daily tolerable enteral nutrition 2) Intestinal motility indicators: the levels of serum motilin and gastrin 3) Intestinal barrier indicators: the levels of serum diamine oxidase (DAO), D-lactic acid and I-FABP 2)Secondary outcome# Duration of mechanical ventilation in patients with endotracheal intubation on ICU admission; Length of stay in ICU and Length of stay in hospital; 30-day life quality and cognitive function after surgery; All-cause 28-day mortality.

  9. The estimated duration of the study#1-2years.

Full description

This study is a randomized, double-blinded, placebo controlled and long-term follow-up design. In this study, ST36 (Zusanli) and ST37 (Shangjuxu) were selected for electroacupuncture treatment, accompanied with evaluating the effects on intestinal function in septic patients. Meanwhile, the blood biochemical indexes such as heme oxygenase-1(HO-1), PTEN induced putative kinase 1(PINK1), polo-like kinase 1(PLK1) and interleukin-6 are detected. To clarify the effect of electroacupuncture on sepsis-induced intestinal dysfunction is of great significance to the clinical applications and popularization of traditional acupuncture treatment across the world.

Enrollment

30 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Meet the diagnostic criteria of sepsis 3.0
  2. AGI grade II or above,
  3. At least 18 years old
  4. Volunteer to participate in this study and sign the informed consent form

Exclusion criteria

  1. Patients with bowel dysfunction caused by other diseases or surgical operations
  2. Those who have chronic gastrointestinal diseases such as Crohn's disease and ulcerative colitis
  3. Those who have recently used gastrointestinal motility drugs and within 5 times the half-life
  4. Those who are participating in other drug clinical trials
  5. Refuse to participate in this study

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

30 participants in 2 patient groups

electroacupuncture treatment
Experimental group
Description:
Participants in the treatment group underwent 60 minutes acupuncture (0.30mm×70mm) at ST36 (Zusanli) and ST37 (Shangjuxu) twice a day for seven days. After"Deqi",electroacupuncture stimulation apparatus (HANS G6805-2, Huayi Co, Shanghai, China) isconnected and maintained the end of treatment
Treatment:
Device: electroacupuncture treatment
sham electroacupuncture treatment
Sham Comparator group
Description:
sham electroacupuncture treatment participants in the control group received shallow needling (0.30mm×25mm) at ST36 and ST37(nonacupoints located 1 inch beside acupoints, about 20mm). Specifically, the depth of needle insertion into nonacupoints is 3-5mm and avoided manual stimulation and no "Deqi" without actual current output.
Treatment:
Device: sham electroacupuncture treatment

Trial contacts and locations

1

Loading...

Central trial contact

Yingya Cao, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems